Cardiac rehabilitation still underutilized despite proven benefits

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

NIH wanted to make cancer research more diverse. The effort turned out to be a costly failure

Government researchers hoped to attract a more diverse group of patients for clinical research by paying for the travel expenses of cancer patients seeking to

June 12, 2024

FDA approves Tris Pharma’s non-stimulant pediatric ADHD liquid medication

The FDA approved Tris Pharma’s Onyda XR to treat ADHD in children who are at least 6 years old. It’s the first liquid non-stimulant ADHD

May 30, 2024

Scoop: Infectious disease biotech eyes $25M Series A to advance antibody for chronic lung infection

Infex Therapeutics is planning to raise up to £20 million ($25 million) in a Series A round with an eye to progressing its lead asset

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.